+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Overactive Bladder Treatment Market Report 2026 - Product Thumbnail Image

Overactive Bladder Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Glucagon-like Peptide 1 Market Report 2026 - Product Thumbnail Image

Glucagon-like Peptide 1 Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
Obesity: Competitive Landscape to 2026 - Product Thumbnail Image

Obesity: Competitive Landscape to 2026

  • Report
  • October 2018
  • 50 Pages
  • Global
From
Peptide Synthesis Market Report 2026 - Product Thumbnail Image

Peptide Synthesis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Hemophilia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 182 Pages
  • Global
From
From
From
From
Skeletal Dysplasia Market - Global Strategic Business Report - Product Thumbnail Image

Skeletal Dysplasia Market - Global Strategic Business Report

  • Report
  • April 2026
  • 378 Pages
  • Global
From
From
Biopharmaceuticals - Global Strategic Business Report - Product Thumbnail Image

Biopharmaceuticals - Global Strategic Business Report

  • Report
  • April 2026
  • 262 Pages
  • Global
From
From
From
From
From
Loading Indicator